Biogen Idec (NQ: BIIB )
241.75 USD -0.76 (-0.31%) Official Closing Price Updated: 7:59 PM EST, Nov 25, 2020 Add to My Watchlist
Stories about Biogen Idec
Biogen is joining the hunt for a coronavirus treatment with Vir Biotechnology. Further, the company is working on an Alzheimer's drug. So, is now the time to buy Biogen stock?
Better Buy: Gilead Sciences vs. Biogen
June 18, 2020
One of these pharmaceutical giants has the only reasonably effective treatment so far for COVID-19, while the other has high hopes for its Alzheimer's disease drug candidate.
Here are the best and worst stocks during the first 100 days of the coronavirus pandemic
June 17, 2020
Notable Tuesday Option Activity: BIIB, KR, HRB
June 16, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Biogen Inc (BIIB), where a total volume of 6,360 contracts has been traded thus far...
Implied MOAT Analyst Target Price: $58
June 15, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics
June 14, 2020
IBB, VRTX, BIIB, ILMN: Large Outflows Detected at ETF
June 12, 2020
Symbols mentioned in this story: IBB, VRTX, BIIB, ILMN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
BIIB Makes Notable Cross Below Critical Moving Average
June 11, 2020
In trading on Thursday, shares of Biogen Inc (BIIB) crossed below their 200 day moving average of $287.39, changing hands as low as $281.20 per share. Biogen Inc shares are currently trading down about...
Should You Sell Biogen Stock?
June 10, 2020
With the biotech facing two issues each that could result in major headwinds, a Bernstein analyst has downgraded its stock.
Benzinga's Top Upgrades, Downgrades For June 9, 2020
June 09, 2020
Upgrades B of A Securities upgraded the stock forOccidental Petroleum Corp(NYSE: OXY) from Neutral to Buy. Occidental ...
The weekend was abuzz with rumors of U.K. pharma giant AstraZeneca plc's (NYSE: AZN) reported interest in U.S.-based large-cap ...
Noteworthy Monday Option Activity: NAT, ZGNX, BIIB
June 08, 2020
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Nordic American Tankers Ltd (NAT), where a total of 40,927 contracts have traded so far,...
The company is an aggressive newcomer to the infectious-disease market and its COVID-19 programs are very promising.
Better Buy: Biogen vs. Axsome Therapeutics
May 23, 2020
One biotech has been big long-time winner, the other is a promising up-and-comer with no revenue -- yet. But picking an investment is always a bet on the future.
Noteworthy ETF Outflows: IVE, IBM, FIS, BIIB
May 22, 2020
Symbols mentioned in this story: IVE, IBM, FIS, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Hedge funds have relied on technology, internet, media and telecom companies and increasingly more health care companies to drive performance.
Biogen is joining the hunt for a coronavirus treatment with Vir Biotechnology. Further, the company is still working on an Alzheimer's drug. So, is now the time to buy Biogen stock?
Noteworthy ETF Outflows: MTUM, AMD, BIIB, HUM
May 13, 2020
Symbols mentioned in this story: MTUM, AMD, BIIB, HUM Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Berkshire Hathaway acquired $4 billion in equities during Q1, and these are the companies that were likely purchased.
Although the coronavirus seems to be opening up opportunities for biotech companies, it is dampening their guidance as well. Despite impressive results, most of these biotechs have been seeing...
From Blogs - TalkMarkets
Apple Inc on Monday capitalized on the Federal Reserve's emergency measures in response to the coronavirus outbreak to issue its cheapest bonds in years, making it the latest blue-chip company to do so...
Why Biogen Shares Fell 6.18% in April
May 04, 2020
Has Biogen Found the Answer to Treating Alzheimer's?
May 01, 2020
Next Support Level for Biogen Inc (BIIB) is $295.81
April 30, 2020
Biogen Inc (NASDAQ:BIIB) has opened bearishly below the pivot of $299.93 today and has reached the first level of support at $296.77. Analysts will be watching for a cross...